WA
XYL icon

Walsh & Associates’s Xylem XYL Stock Holding History

Walsh & Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
+100
New +$11.5K 0.01% 187

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Walsh & Associates's XYL Position: Q2 2026 in Review

Walsh & Associates opened a new position in Xylem (XYL) in Q2 2026: 100 shares worth $11.9K. The stake represents 0.01% of the portfolio and ranks #187 among its holdings.

1,087 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Walsh & Associates held 100 shares of Xylem worth $11.9K as of Q2 2026.
  • Xylem was a new Walsh & Associates position in Q2 2026.
  • Xylem made up 0.01% of Walsh & Associates's portfolio in Q2 2026, its #187 holding.
  • 1,087 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Walsh & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.